Regulation of bradykinin B 2-receptor expression by oestrogen

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1763-1769

  Madeddu, Paolo ^a,b   Emanueli, Costanza ^c   Varoni, Maria Vittoria ^a   Demontis, Maria Piera ^a   Anania, Vittorio ^a   Gorioso, Nicola ^a,b   Chao, Julie ^d  

^a UNIVERSITY OF SASSARI   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Blood pressure; Bradykinin; Bradykinin B 2 receptors; mRNA; Oestrogen; Ovariectomy; Vasodilatation

Indexed keywords

ACETYLCHOLINE; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ[8 LEUCINE 9 DEARGININE]; ESTRADIOL; ESTRADIOL BENZOATE; ESTROGEN; HYPERTENSIVE FACTOR; MESSENGER RNA; NITROPRUSSIDE SODIUM; PROSTAGLANDIN E2; BRADYKININ RECEPTOR; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; GENE FUNCTION; HEART; HEART PROTECTION; KALLIKREIN KININ SYSTEM; KIDNEY; MALE; MENOPAUSE; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SEX DIFFERENCE; UTERUS; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; SEXUAL DEVELOPMENT; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; BRADYKININ; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; OVARIECTOMY; PROGESTERONE; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; SEX CHARACTERISTICS;

EID: 0030608797     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701255     Document Type: Article

References (40)

1. BARRETT-CONNORS, E. & BUSH, T.L. (1991). Oestrogen and coronary heart disease in women. J. Am. Med. Assoc., 265, 1861-1867.
2. BJORNSTAD-OSTENSEN, A. & BERG, T. (1994). The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension. Br. J. Pharmacol., 113, 1567-1573.
3. BRAYDEN, J.E. & NELSON, M.T. (1992). Regulation of arterial tone by activation of calcium-dependent potassium channels. Science, 256, 532-535.
4. CHEN, L.M., CHUNG, P., CHAO, S., CHAO, L. & CHAO, J. (1992). Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochim. Biophys. Acta, 1131, 145-151.
5. CHERRY, P., FURCHGOTT, R.F., ZAWADZKI, J.V. & JOTHIANANDAN, D. (1982). Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc. Natl. Acad. Sci. U.S.A., 79, 2106-2110.
6. COLDITZ, G.A., WILLETT, W.C., STAMPFER, M.J., ROSNER, N., SPEIZER. F.E. & HENNEKENS, C.H. (1987). Menopause and the risk of coronary heart disease in women. N. Engl. J. Med., 316, 1105-1110.
7. COLLINS, P., RISANO, G.M.C., SARREL, P.M., ULRICH, L., ADAMOPOULOS, S., BEALE, C.M., MCNEIL, J.G. & POOLE-WILSON, P.A. (1995). 17b-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation, 92, 24-30.
8. CROFTON, J.T., SHARE, L. & BROOKS, D.P. (1989). Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in rat. Clin. Exp. Hypertens., 11, 1249-1261.
9. DAVIS, L.G. & BATTEY, J.F. (1986). Basic Methods in Molecular Biology, pp. 130-135. New York, Elsevier Science Publishing Co., Inc.
10. DHAL, L.K., KNUDSEN, K.D., OHANIAN, E.V., MUIRHEAD, M. & TUTHILL, R. (1975). Role of gonads in hypertension prone rats. J. Exp. Med., 142, 748-759.
11. GILLIGAN, D.M., BADAR, D.M., PANZA, J.A., QUYYULI, A.A. & CANNON, R.O. (1994). Acute vascular effects of estrogen in postmenopausal women. Circulation, 90, 786-791.
12. JAMS, S.G. & WEXLER, B.C. (1979). Inhibition of the development of spontaneous hypertension in SH rats by gonadectomy and estradiol. J. Lab. Clin. Med., 10, 608-616.
13. KAUSER, K. & RUBANYI, G.M. (1995). Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rat. Hypertension, 25, 517-523.
14. KIM-SCHULZE, S., MCGOWAN, K.A., HUBCHAK, B.S., CID, M.C., MARTIN, M.B., KLEINMAN, H.K., GREENE, G.L. & SCHNAPER, W. (1996). Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation, 94, 1402-1407.
15. LEHER, S., RABIN, J., KALIR, T. & SCHACHTER, B.S. (1993). Estrogen receptor variant and hypertension in women. Hypertension, 21, 439-441.
16. LIEBERMAN, E.H., GERHARD, M.D., UEHATA, A., WALSH, B.W., SELWYN, A.P., GANZ, P., YEUNG, A.C. & CREAGER, M.A. (1994). Estrogen improves endothelium-dependent flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med., 121, 936-941.
17. LINZ, W., WIEIMER, G., GHOLKE, P., UNGER, T. & SCHOLKENS, B.A. (1995). Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev., 47, 25-49.
18. LUSCHER, T.F., RAIJ, L. & VANHOUTTE, P.M. (1987). Endothelium dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension, 9, 157-163.
19. MADEDDU, P., GLORIOSO, N., MAIOLI, M., DEMONTIS, M.P., VARONI, M.V., ANANIA, V., XIONG, W., CHAI, K. & CHAO, J. (1991). Regulation of rat renal kallikrein expression by estrogen and progesterone. J. Hypertens., 9 (suppl 6), S244-S245.
20. MADEDDU, P., PINNA PARPAGLIA, P., ANANIA, V., GLORIOSO, N., CHAO, C., WANG, C. & CHAO, J. (1996). Sexual dimorphism of cardiovascular responses to early blockade of bradykinin receptors. Hypertension, 27, 746-751.
21. MONCADA, S. & VANE, J.R. (1978). Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol. Rev., 30, 293-331.
22. MURRAY, S.R., CHAO, J., LIN, F.K. & CHAO, L. (1990). Kallikrein multigene families and the regulation of their expression. J. Cardiovasc. Pharmacol., 15 (suppl 6), S7-S16.
23. NAKASHIMA, M., MOMBOULI, J.-V., TAYLOR, A.A. & VANHOUTTE, P.M. (1993). Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J. Clin. Invest., 92, 2867-2871.
24. PARRATT, J.R. (1994). Protection of the heart by ischemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol. Sci., 15, 19-25.
25. PROUDLER, A.J., AHMED, A., CROOK, D., FOGELMAN, L., RYMER, J.M. & STEVENSON, J.C. (1995). Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women. Lancet, 346, 89-90.
26. REGOLI, D. & BARABE, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
27. REIS, S.E., GLOTH, S.T., BLUMENTHAL, R.S., RESAR, J.R., ZACUR, H.A., GERSTENBLITH, G. & BRINKER, J.A. (1994). Ethinyl estradiol acutely attenuates abnormal coronary responses to acetylcholine in postmenopausal women. Circulation, 89, 52-60.
28. RIEDEL, M., RAFFENBEUL, W. & LICHTLEN, P. (1993). Ovarian sex steroids and atherosclerosis. Clin. Invest., 71, 406-412.
29. SHAN, J., RESNICK, L.M., LIU, Q.Y., WE, X.C., BARBAGALLO, M. & PANG, P.T.K. (1994). Vascular effects of 17β-estradiol in male Sprague-Dowley rats. Am. J. Physiol., 35, H967-H973.
30. STAMPFER, M.J., COLDITZ, G.A., WILLETT, W.C., MANSON, J.A., ROSNER, B., SPEIZER, F.E. & HENNEKENS, C.H (1991). Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from Nurses' Health Study. N. Engl. J. Med., 325, 756-762.
31. + channels in arterial smooth muscle. Science, 245, 177-180.
32. SUDHIR, K., JENNING, G.L., FUNDER, J.W. & KOMESAROFF, P.A. (1996). Estrogen enhances basal nitric oxide release in the forearm vasculature of perimenopausal women. Hypertension, 28, 330-334.
33. TADDEI, S., VIRDIS, A., GHIADONI, L., MATTEI, P., SUDANO, I., BERNINI, G., PINTO, S. & SALVETTI, A. (1996). Menopause is associated with endothelial dysfunction in women. Hypertension, 28, 576-582.
34. THE WRITING GROUP FOR THE PEPI TRIAL. Effects of estrogen or estrogen/progestinic regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestinic Interventions (PEPI) Trial. J. Am. Med. Assoc., 273, 199-208.
35. VENKOV, C.D., RANKIN, A.B. & VAUGHAN, D.E. (1996). Identification of authentic estrogen receptor in cultured endothelial cells: A potential mechanism for steroid hormone regulation of endothelial function. Circulation, 94, 727-733.
36. WAGNER, J.D., CLARKSON, T.B., STCLAIR, R.W., SCHWENKE, D.C., SHIVELY, C.A. & ADAMS, M.R. (1991). Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J. Clin. Invest., 88, 1995-2002.
37. WEINER, C.P., LIZASOAIN, I., BAYLIS, S.A., KNOWLES, R.G., CHARLES, I.G. & MONCADA, S. (1994). Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. U.S.A., 91, 5212-5216.
38. WILLIAMS, J.K., ADAMS, M.R. & KLOPFENSTEIN, H.B. (1990). Estrogen modulates responses of atherosclerotic coronary arteries. Circulation, 81, 1680-1687.
39. WILLIAMS, J.K., ADAMS, M.R., HERRINGTON, D.M. & CLARKSON, T.B. (1992). Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Coll. Cardiol., 20, 452-457.
40. YALLAMPALLI, C., MYAM-SMITH, M., NELSON, S.O. & GARFIELD, R.E. (1994). Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology, 134, 1971-1974.